Cara Therapeutics Inc (CARA)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 10.81M | 3.26M | 6.17M | 6.93M | 4.87M | 3M | 2.14M | 991k |
営業利益 | -23.85M | -31.31M | -27.65M | -32.34M | -28.9M | -32.61M | -29.67M | -17.31M |
税引前収入 | -23.18M | -30.34M | -26.67M | -31.48M | -28.03M | -32.34M | -30.7M | -20.02M |
純利益 | -23.18M | -30.34M | -26.67M | -31.48M | -28.03M | -32.34M | -30.7M | -20.02M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -23.18M | -30.34M | -26.67M | -31.48M | -28.03M | -31.73M | -28.71M | -16.62M |
EBITDA | -23.78M | -31.25M | -27.59M | -32.28M | -28.84M | -32.53M | -29.62M | -17.23M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 86k | 911k | 13.47M | 19.89M | 135.08M | 23.03M | 41.87M | 20.97M |
営業利益 | -58.4M | -59.49M | -77.38M | -111.68M | 5.39M | -89.08M | -87.54M | -121.5M |
税引前収入 | -57.75M | -58.33M | -74.4M | -107.19M | 7.72M | -88.44M | -85.47M | -118.51M |
純利益 | -57.28M | -58.13M | -74.01M | -106.37M | 8.41M | -88.44M | -85.47M | -118.51M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.098 | -1.78 | -1.871 | -2.277 | 0.169 | -1.654 | -1.589 | -2.175 |
EBIT | -57.75M | -58.33M | -74.4M | -107.19M | 7.72M | -88.44M | -85.47M | -117.91M |
EBITDA | -56.94M | -58.99M | -77.01M | -111.48M | 5.59M | -88.84M | -87.29M | -121.24M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約